Your browser doesn't support javascript.
loading
Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial.
Sandborn, William J; Panés, Julian; Danese, Silvio; Sharafali, Zaineb; Hassanali, Azra; Jacob-Moffatt, Rhian; Eden, Christopher; Daperno, Marco; Valentine, John F; Laharie, David; Baía, Carolina; Atreya, Raja; Panaccione, Remo; Rydzewska, Grazyna; Aguilar, Humberto; Vermeire, Séverine.
Afiliação
  • Sandborn WJ; Department of Gastroenterology, University of California San Diego, La Jolla, CA, USA.
  • Panés J; Biomedical Research Networking Center in Hepatic and Digestive Diseases, August Pi i Sunyer Biomedical Research Institute, Hospital Clinic of Barcelona, Barcelona, Spain.
  • Danese S; Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy.
  • Sharafali Z; Genentech, San Francisco, CA, USA.
  • Hassanali A; Genentech, San Francisco, CA, USA.
  • Jacob-Moffatt R; F Hoffmann-La Roche, Basel, Switzerland.
  • Eden C; Genentech, San Francisco, CA, USA.
  • Daperno M; SC Gastroenterologia AO Ordine Mauriziano di Torino, Turin, Italy.
  • Valentine JF; Division of Gastroenterology, Hepatology and Nutrition, University of Utah, Salt Lake City, UT, USA.
  • Laharie D; Centre Hospitalier Universitaire de Bordeaux, Hôpital Haut-Lévêque, Service d'Hépato-gastroentérologie et Oncologie Digestive - Université de Bordeaux, Bordeaux, France.
  • Baía C; Médica Gastroenterologista em Belo Horizonte, Minas Gerais, Brazil.
  • Atreya R; Medical Clinic 1, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany.
  • Panaccione R; Division of Gastroenterology and Hepatology, University of Calgary, Calgary, AB, Canada.
  • Rydzewska G; Central Clinical Hospital of the Ministry of Interior in Warsaw, Warsaw, Poland.
  • Aguilar H; GastroIntestinal Specialists, Shreveport, LA, USA.
  • Vermeire S; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium. Electronic address: severine.vermeire@uzleuven.be.
Lancet Gastroenterol Hepatol ; 8(1): 43-55, 2023 Jan.
Article em En | MEDLINE | ID: mdl-36240801
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doença de Crohn Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Revista: Lancet Gastroenterol Hepatol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doença de Crohn Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Revista: Lancet Gastroenterol Hepatol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos